Projects per year
Personal profile
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
R2060CNR: CURED Study: Characterising drivers of therapeutic Resistance in paediatric AML
Lappin, K. (PI), Greenfield, G. (CoI) & Longley, D. (CoI)
09/10/2023 → …
Project: Research
-
R2739CNR: Leukaemia & Lymphoma via QUB Foundation - Research Fellow & Technician
Lappin, K. (PI) & Mills, K. (CoI)
03/08/2020 → …
Project: Research
-
-
R2557CNR: Identifying Combination Therapies Targeting Apoptosis Pathways in Paediatric AML (CAuSAL study)
Mills, K. (PI) & Lappin, K. (CoI)
11/02/2019 → 28/02/2021
Project: Research
-
The cancer-associated SF3B1K700E spliceosome mutation confers enhanced sensitivity to BV-6-induced cytotoxicity
Roets, L. E., Blayney, J. K., McMillan, H. P., Preston, P. J., Mutch, A. M., Mills, K. I., Savage, K. I. & Lappin, K. M., 01 Jul 2025, In: Cell, Death & Disease. 16, 11 p., 476.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Platelet pathogen reduction technology - should we stay or should we go. . .?
Piccin, A., Allameddine, A., Spizzo, G., Lappin, K. M. & Prati, D., 10 Sept 2024, In: Journal of Clinical Medicine. 13, 18, 17 p., 5359.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)63 Downloads (Pure) -
Poster abstract: Investigating the potential of spliceosome mutations to be used as biomarkers for directing immune checkpoint blockade therapies in myeloid malignancies
Briggs, R., McMillan, H., Roets, L. E., Savage, K. I. & Lappin, K. M., 05 Nov 2024, In: Blood. 144, Supplement 1, p. 4110 1 p.Research output: Contribution to journal › Meeting abstract › peer-review
-
Combination therapies targeting apoptosis in paediatric AML: understanding the molecular mechanisms of AML treatments using phosphoproteomics
Ali, A. A., Cairns, L. V., Clarke, K. M., Blayney, J. K., Lappin, K. M. & Mills, K. I., 16 Mar 2023, In: International Journal of Molecular Sciences. 24, 6, 22 p., 5717.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)90 Downloads (Pure) -
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
Lappin, K. M., Barros, E. M., Jhujh, S. S., Irwin, G. W., McMillan, H., Liberante, F. G., Latimer, C., LaBonte, M. J., Mills, K. I., Harkin, D. P., Stewart, G. S. & Savage, K. I., 03 Mar 2022, In: Cancer Research. 82, 5, p. 819-830 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile39 Citations (Scopus)190 Downloads (Pure)
Activities
-
Gary Middleton
Lappin, K. (Host)
04 Mar 2025Activity: Hosting a visitor types › Hosting an academic visitor
-
Nature (Journal)
Lappin, K. (Peer reviewer)
2025Activity: Publication peer-review and editorial work types › Publication peer-review
-
The American Society of Hematology (External organisation)
Lappin, K. (Member)
2025Activity: Membership types › Membership of network
-
Supervisor Training 15/11/24
Lappin, K. (Participant)
15 Nov 2024Activity: Other activity types › Other
-
British Council - ISPF reviewer (External organisation)
Lappin, K. (Reviewer)
12 Aug 2024 → 30 Nov 2030Activity: Membership types › Membership of peer review panel or committee
Press/Media
-
‘Without You’ publicity campaign (2024) – Leukaemia and Lymphoma NI
01/06/2024
1 Media contribution
Press/Media: Public Engagement Activities
-
Social Media – International Day of Women and Girls in Science
08/03/2024
1 Media contribution
Press/Media: Other
-
Discover new cancer treatments using drugs already approved for clinical use – so they get to patients quicker
01/06/2023
1 Media contribution
Press/Media: Research
-
QUEEN’S RESEARCHERS INVESTIGATE NEW ‘TARGETED THERAPY’ FOR PAEDIATRIC ACUTE MYELOID LEUKAEMIA
06/11/2020
1 item of Media coverage
Press/Media: Research
-
Blood cancer case drop during pandemic 'a real concern' say Leukaemia & Lymphoma NI
01/10/2020
1 item of Media coverage
Press/Media: Research